<html>
<head>PUBMED IDs for ITIH5</head>
<body bgcolor='#C5F0F2'><h1>ITIH5</h1><a href='https://pubmed.ncbi.nlm.nih.gov/14744536/'>ITIH5, a novel member of the inter-alpha-trypsin inhibitor heavy chain family is downregulated in breast cancer.</a> January 28  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/17653090/'>The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.</a> July 27  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18810445/'>[Novel prognostic marker in invasive breast cancer. ITIH5 expression is abrogated by aberrant promoter methylation].</a> September 24  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/21139803/'>Cross-species comparison of orthologous gene expression in human bladder cancer and carcinogen-induced rodent models.</a> December 9  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/23539898/'>Involvement of ITIH5, a candidate gene for congenital uterovaginal aplasia (Mayer-Rokitansky-Küster-Hauser syndrome), in female genital tract development.</a> April 30  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23539898/'>Involvement of ITIH5, a candidate gene for congenital uterovaginal aplasia (Mayer-Rokitansky-Küster-Hauser syndrome), in female genital tract development.</a> April 30  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22704354/'>Aberrant DNA hypermethylation of the ITIH5 tumor suppressor gene in acute myeloid leukemia.</a> June 19  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23320751/'>Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening.</a> March 13  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23446731/'>Genome-wide analysis of DNA methylation in tongue squamous cell carcinoma.</a> March 7  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24265292/'>Epigenetic inactivation of ITIH5 promotes bladder cancer progression and predicts early relapse of pT1 high-grade urothelial tumours.</a> May 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24516561/'>A gene expression and pre-mRNA splicing signature that marks the adenoma-adenocarcinoma progression in colorectal cancer.</a> January 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24913813/'>Decreased ITIH5 expression is associated with poor prognosis in primary gastric cancer.</a> July 25  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25093535/'>Epigenetic inactivation of the novel candidate tumor suppressor gene ITIH5 in colon cancer predicts unfavorable overall survival in the CpG island methylator phenotype.</a> May 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25809190/'>Inter-α-trypsin inhibitor heavy chain 5 (ITIH5) is overexpressed in inflammatory skin diseases and affects epidermal morphology in constitutive knockout mice and murine 3D skin models.</a> June 9  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25861810/'>Impact of age, BMI and HbA1c levels on the genome-wide DNA methylation and mRNA expression patterns in human adipose tissue and identification of epigenetic biomarkers in blood.</a> April 29  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26252352/'>Low expression of ITIH5 in adenocarcinoma of the lung is associated with unfavorable patients' outcome.</a> August 2  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/28059468/'>Gene expression analysis combined with functional genomics approach identifies ITIH5 as tumor suppressor gene in cervical carcinogenesis.</a> January 7  2017<br></body></html>
